The effect of injectable barium selenate on the selenium status of horses on pasture

Abstract

Aim. To examine the effect of intramuscular barium selenate on the blood selenium concentration of horses with marginal selenium status.

Methods. Eighteen mares were assigned to one of six groups. The mares in groups 1–4 received barium selenate at 0.5, 0.75, 1.0 and 1.5 mg Se/kg, respectively, injected into the right pectoral muscle mass. The mares in group 5 received sodium selenate at 0.05 mg Se/kg orally at 8-week intervals. The mares in group 6 were left untreated. Ellood samples were collected at 0, 1, 2, 5, 10, 30, 60, 90, 120, 180, 240, 300 and 360 days after the initial treatment for assay of whole blood and plasma selenium. Injection site reactions were recorded on each sampling date.

Results. Treatment with barium selenate at each dose rate significantly increased whole blood, plasma and blood cell selenium concentrations when compared to no treatment or oral treatment with sodium selenate, and maintained group mean whole blood selenium concentrations in the adequate range (> 1600 nmol/1) until the end of the experimental period of 1 year. The severity of injection site reactions increased with dose rate but was considered acceptable at the lower dose rates used.

Conclusion. The injection of barium selenate placed aseptically at a deep intramuscular site was efficacious in correcting the selenium status of mares grazing pasture with a selenium content of 0.01–0.07 mg/kg DM. However, some swelling and fibrosis at the injection site was apparent at all dose rates used.

Clinical relevance. There is currently no long-acting selenium supplementation product licensed in New Zealand for use in horses. Barium selenate promises to provide a useful method for selenium supplementation for horses, with an effective duration of at least 1 year following a single injection.

KEY WORDS:

• Selenium deficiency
• selenium supplementation
• horses